So you have sameness issues now that are kind of initiated from the innovator brand side of the equation.
Editor's note · Context
Sarbanes discusses issues related to sameness in drug labeling.
Share
More from John Sarbanes
Last year, as you know, Congress finally--finally, after many, many decades, really--took the historic step of standing up to Big Pharma and enacting policies that are already--we are seeing it--lowering healthcare costs for millions of…
Congress gave EPA this role more than 50 years ago under the Clean Air Act and reaffirmed that responsibility in 2005 under the Energy Policy Act.
Thank you very much. And I appreciate you talking about the data, the importance of collecting information on where the shortages are.
I have to say when we passed that Inflation Reduction Act, it was the first time in a long time that I did not feel powerless or feel that we were powerless in the face of climate change coming at us.





